Ten63 Therapeutics

About:

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

Website: https://www.ten63tx.com/

Twitter/X: gavilanbio

Top Investors: IndieBio, Alexandria Venture Investments, Draper Associates, SOSV, Hatteras Venture Partners

Description:

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

Total Funding Amount:

$15.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)gavilanbio.com

Founders:

Jonathan Jou, Marcel Frenkel, Mark Hallen

Number of Employees:

11-50

Last Funding Date:

2023-05-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai